Method for producing regenerated human skin tissue
By culturing adipose tissue stem cells with fibroblasts and keratinocytes, melanocyte precursor cells are differentiated into mature melanocytes, addressing the limitations of ES cells and bone marrow mesenchymal cells, resulting in easily obtainable and functional skin tissue for skin disease treatment and aging skin.
Patent Information
- Application Number
- JP2020122407
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2020-07-16
- Publication Date
- 2024-11-01
- Estimated Expiration
- 2040-07-16
AI Technical Summary
The induction rate of differentiation of ES cells and iPS cells into epidermal keratinocytes is low, and there are concerns about tumor formation, while bone marrow mesenchymal cells are difficult to collect.
Utilizing adipose tissue stem cells, which naturally contain melanocyte precursor cells, and culturing them with fibroblasts and keratinocytes in a melanocyte-specific medium to produce regenerated human skin tissue containing mature melanocytes, keratinocytes, and fibroblasts.
Adipose tissue-derived stem cells are easily obtainable and abundant, with induced melanocytes having low antigenicity, enabling the production of functional skin tissue for treating various skin diseases and aging skin.
Smart Images

Figure 0007576821000001 
Figure 0007576821000002 
Figure 0007576821000003
Abstract
Description
[Technical field]
[0001] The present invention relates to a method for producing regenerated human skin tissue. [Background technology]
[0002] Transplantation of autologous and allogeneic (allogeneic) cultured skin and pigment cells is being performed as a means of treating skin diseases such as severe burns, skin ulcers, segmental vitiligo, etc. Attempts are also being made to use ES cells, iPS cells (Non-Patent Document 1), mesenchymal stem cells (Non-Patent Documents 2 and 3), Muse cells (Non-Patent Documents 4 and 5), etc. in regenerative medicine for the skin. [Prior art documents] [Non-patent literature]
[0003] [Non-Patent Document 1] PLoS One, 2012:7(12):e52787 [Non-Patent Document 2] Am. J. Pathol. 173:803-814,2008 [Non-Patent Document 3] Immunotherapy 4:1859-1867, 2012 [Non-Patent Document 4] Proc. Natl. Acad. Sci. USA 107:8639-8643, 2010 [Non-Patent Document 5] Proc. Natl. Acad. Sci. USA 108:9875-9880, 2011 Summary of the Invention [Problem to be solved by the invention]
[0004] However, the differentiation of ES cells and iPS cells into epidermal keratinocytes has a low induction rate and there is a problem of the possibility of tumor formation. Also, bone marrow mesenchymal cells are difficult to collect. Therefore, there is a need for the development of a method for producing regenerated skin tissue using readily available cells, and the present invention provides a method for producing regenerated skin tissue containing keratinocytes, melanocytes and fibroblasts. [Means for solving the problem]
[0005] Therefore, the present inventors have been studying subcutaneous adipose tissue, which is easily harvestable, and have unexpectedly found that melanocyte precursor cells are already present in adipose tissue stem cells before differentiation induction. They have also found that when these melanocyte precursor cells are cultured in a melanocyte-specific medium, they clearly express melanocyte-specific marker proteins. They have also found that when these melanocyte precursor cells are cultured together with human fibroblasts and human keratinocytes, regenerated human skin tissue containing human mature melanocytes, human keratinocytes, and human fibroblasts can be obtained, thus completing the present invention.
[0006] That is, the present invention provides the following [1] to [3]. [1] A method for producing regenerated human skin tissue containing human mature melanocytes, human keratinocytes and human fibroblasts, characterized by culturing human adipose tissue stem cells containing human melanocyte precursor cells together with human fibroblasts and human keratinocytes. [2] The method for producing regenerated human skin tissue described in [1], wherein the human adipose tissue stem cells containing human melanocyte precursor cells are human adipose tissue stem cells containing human melanocyte precursor cells, or human adipose tissue stem cells containing human melanocyte precursor cells cultured in a melanocyte-specific medium. [3] A method for producing regenerated human skin tissue described in [1] or [2], wherein the culture system performed together with the human fibroblasts and human keratinocytes is a system in which human fibroblasts, human keratinocytes and the human adipose tissue stem cells are cultured in a collagen gel. Effect of the Invention
[0007] The adipose tissue-derived stem cells used in the present invention can be cultured at approximately 5×103 The number of stem cells derived from adipose tissue is 500 times higher than that of stem cells derived from bone marrow tissue, and they are easily obtained. In addition, since adipose tissue-derived stem cells have low antigenicity and immunosuppressive effect, human mature melanocytes induced to differentiate from them also have low antigenicity and can be transplanted into the skin. In addition, the regenerated skin tissue obtained by the present invention contains not only human keratinocytes and human mature melanocytes but also fibroblasts, and has the functions of the epidermis, basal layer, and dermis of the skin, so that it is possible to treat various skin diseases and aging skin. [Brief description of the drawings]
[0008] [Figure 1] 1 shows the results of immunostaining of adipose tissue stem cells. [Diagram 2] 1 shows the results of immunostaining of adipose tissue stem cells. [Figure 3-1] RT-PCR results of adipose tissue stem cells are shown. [Figure 3-2] RT-PCR results of adipose tissue stem cells are shown. [Figure 4] The results of knocking down HMB45 in adipose tissue stem cells using the siRNA method are shown. [Diagram 5] 1 shows the results of Western blotting of adipose tissue stem cells. [Figure 6] 1 shows the results of Western blotting of adipose tissue stem cells. [Figure 7] 1 shows the results of immunoelectron microscopy of adipose tissue stem cells. [Figure 8] The expression of HMB45 and tyrosinase (TYR) in tissues after 3D culture is shown. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0009] The present invention provides a method for producing regenerated human skin tissue containing human mature melanocytes, human keratinocytes and human fibroblasts, which is characterized by culturing human adipose tissue stem cells containing human melanocyte precursor cells together with human fibroblasts and human keratinocytes.
[0010] The starting material for the production method of the present invention is human adipose tissue stem cells containing human melanocyte precursor cells. The adipose tissue stem cells as the raw material can be collected by treating adipose tissue, for example subcutaneous adipose tissue, with collagenase, followed by separation of stromal vascular cells by centrifugation. The cells obtained can be confirmed to be adipose tissue stem cells by confirming that (1) they are positive for CD34, CD44, CD90, and CD105, and (2) they differentiate into adipocytes when cultured in the presence of 3-isobutyl-1-methylxanthine, biotin, pantothenate, rosiglitazone, dexamethasone, insulin, etc. The adipose tissue stem cells may be derived from animals, including humans, that do not cause rejection in the patient, but autologous cells are preferable.
[0011] The present inventors have found for the first time that human melanocyte precursor cells exist in human adipose tissue stem cells isolated from subcutaneous adipose tissue, which is easy to collect. That is, as shown in the examples below, a) immunostaining shows that melanocyte marker proteins MelanA, MATP, HMB45 (premelanosome protein), LAMP1, MITF, TYR, MelEM, and Mel2 are expressed in human adipose tissue stem cells before differentiation induction, b) RT-PCR shows that melanocyte transcription factors MITF, KIT, and PAX3 are expressed in human adipose tissue stem cells before differentiation induction, c) knocking down HMB45 in human adipose tissue stem cells using the siRNA method causes the expression of HMB45 in these cells to disappear, d) Western blotting shows that HMB45 and MITF are expressed in human adipose tissue stem cells before differentiation induction, and e) immunoelectron microscopy also shows that HMB45 is expressed in adipocyte stem cells before differentiation induction. In the present invention, human adipose tissue stem cells containing human melanocyte precursor cells can be used in this manner.
[0012] In addition, when human adipose tissue stem cells containing human melanocyte precursor cells are cultured in a melanocyte-specific medium, the expression of melanocyte marker protein is further enhanced, so in the present invention, it is more preferable to use human adipose tissue stem cells that are cultured in a melanocyte-specific medium containing human melanocyte precursor cells. Here, the enhanced expression of melanocyte marker protein can be confirmed by the above-mentioned immunostaining, RT-PCR, HMB45 knockdown by siRNA method, Western blotting, and immunoelectron microscopy. An example of a melanocyte-specific medium that can be used is KURABO's DermaLife (registered trademark) BM (KURABO) as a basal medium supplemented with DermaLife (registered trademark) M LifeFactors (15 mL of L-glutamine, 0.5 mL of epinephrine, 0.5 mL of insulin, 5 mL of StiMel8 (registered trademark) LifeFactor, 0.5 mL of ascorbic acid, 1.0 mL of calcium chloride, and 0.5 mL of gentamicin / amphotericin). In addition, a medium containing the above medium further supplemented with Wnt3a (R&D systems (registered trademark)) at 50 ng / ml, Endothelin3 (SIGMA-ALDRICH) at 100 nM, SCF (R&D systems (registered trademark) at 10 ng / mL, cholera toxin (FUJIFILM) at 1.66 mg / L, and Linoleic acid (Nacalai) at 25 μM in ethanol can also be used.
[0013] To culture human adipose tissue stem cells in a melanocyte-specific medium, for example, human adipose tissue stem cells are seeded on a petri dish coated with collagen IV (5 μg / mL Nitta Gelatin) and cultured for about 3 to 7 days using a medium dedicated to human adipose tissue stem cells (ADSC-BM, LONZA).The medium is then replaced with a melanocyte-specific medium, and cultured for about 7 to 14 days.
[0014] Human adipose tissue stem cells containing human melanocyte precursor cells are cultured with human fibroblasts and human keratinocytes. As the human fibroblasts, human dermal fibroblasts are preferred. Fibroblasts can be collected from connective tissue; for example, a piece of skin with a diameter of 5 mm is excised and the fibroblasts can be collected from the dermis. As human keratinocytes, for example, frozen NHEK from KURABO can be used.
[0015] As a means for co-culturing these cells, a three-dimensional culture method is preferred, and from the viewpoint of regenerating skin tissue, a system in which human fibroblasts, human keratinocytes, and the human adipose tissue stem cells are cultured in a collagen gel is more preferred. Furthermore, since in skin tissue, the epidermis containing melanocytes and keratinocytes is present above the dermis containing fibroblasts via the basal layer, a three-dimensional culture system in which human keratinocytes in which fibroblasts are embedded and cultured in a collagen gel and the human adipose tissue stem cells are layered and cultured is preferred. Here, the collagen gel is preferably type I or type IV collagen gel. The culture conditions for the 3D culture method are as follows: First, coat the 6-well plate (IWAKI) and the transwell with collagen IV (5 μg / mL). Then, 5.0x10 fibroblasts are placed on the transwell. 4 ~1.0x10 5 The cells were embedded in collagen I gel at 100x10 cells / well and cultured for about 2 days. After 2 days, 2.5x10 human adipose tissue-derived stem cells induced to melanocytes were seeded on top. 4 ~5.0x10 4 cells / well. NHEK cells were then seeded on top at 5.0x10 4 ~1.0x10 5The cells are seeded at 100 cells / well and then cultured for approximately 14-15 days. For the culture medium, use 10% FBS-containing DMEM High Glucose (Nacalai Tesque) as NHDF Medium in the lower 6-well (2ml / well). Add 500μL of the above melanocyte-specific medium and 500μL of HuMedia-KG2 (insulin, hEGF, hydrocortisone, and BPE added; Kurabo) as NHEK Medium to the upper trans well. It is recommended to change the medium about once every two days.
[0016] By such three-dimensional culture, human mature melanocytes are induced in the basal layer of the epidermis, and the obtained three-dimensional cultured skin is a regenerated human skin tissue containing human mature melanocytes, human keratinocytes, and human fibroblasts. Here, differentiation of human melanocyte precursor cells into human mature melanocytes can be confirmed by the expression of tyrosinase, an enzyme essential for melanin synthesis.
[0017] According to the method of the present invention, human adipose tissue stem cells, which are easily available, are used as a raw material, and regenerated human skin tissue containing human mature melanocytes, human keratinocytes, and human fibroblasts can be obtained by simple operations. Therefore, according to the present invention, it is possible to regenerate epidermis, hair, etc. Furthermore, by examining the process of the production method of the present invention, it is possible to research means for treating skin diseases and means for dealing with aging skin. EXAMPLES
[0018] The present invention will now be described in more detail with reference to examples, but the present invention is not limited to these examples.
[0019] Materials and Methods (1) Collection of human adipose tissue stem cells 1) Subcutaneous adipose tissue was collected and washed with phosphate-buffered saline. After soaking in collagenase, the collagenase was neutralized with Dulbecco's modified Eagle's medium containing 10% calf serum. 2) The residue was removed by passing through a 40 μm nylon mesh. The precipitate was collected by centrifugation at 1200 rpm for 10 minutes. It was dissolved again in 5 ml of Dulbecco's modified Eagle's medium containing 10% calf serum, seeded on a culture plate, and cultured for several days. The adipose tissue stem cells were attached to the bottom of the culture plate. 3) Flow cytometry confirmed that CD34, CD44, CD90, and CD105 were positive. 4) The obtained cells were seeded and cultured in D-MEM / Ham's F-12 medium containing 10% calf serum, then changed to D-MEM / Ham's F-12 medium containing 3% calf serum, 3-isobutyl-1-methylxanthine, biotin, panthothenate, rosiglitazone, dexamethasone, and human insulin, and cultured for 3 days. Next, the medium was changed to one without 3-isobutyl-1-methylxanthine, and the medium was changed every 3 days and cultured for about 12 days. The cells were confirmed to have differentiated into adipocytes by staining with Oil red O. The above steps 3) and 4) confirmed that the cells were adipose tissue stem cells.
[0020] (2) Human fibroblasts The skin was cut into pieces with a diameter of 5 mm, and the dermal components were harvested. Specifically, fibroblasts were harvested from the skin of patients who had given their consent and were then cultured.
[0021] (3) Human keratinocytes Frozen NHEK from KURABO was used.
[0022] (4) Immunostaining Multiple staining for HMB45, and immunostaining for MelanA, MATP, MelEM, MITF, Tyrosinase, and Mel2. A cover glass was placed on a Nunc4well plate and coated with collagen IV. Induced human adipose tissue-derived stem cells, human adipose tissue-derived stem cells, and melanoma cells were cultured on the cover glass until they reached about 60-70%. Fix with 4% paraformaldehyde at room temperature for 15 minutes. Block with 10% Normal Goat Serum and 0.1% saponin or 0.1% Triton / PBS. 2%BSA / PBS with 0.1% saponin, or 2%BSA / PBS alone with primary antibodies Anti-HMB45 antibody (Abcam ab733 Mouse monoclonal IgG) diluted 1 / 50 and Anti-LAMP1 antibody-Lysosome Marker (Abcam ab24170 Rabbit polyclonal IgG) diluted 1 / 500, or MelEM_DSHB (added undiluted, Developmental studies hybridoma bank, host mouse), Anti-MITF antibody (ab20663 Abcam Biotechnology, host rabbit) 1 / 250, Anti-Melan A antibody (ab210546 Abcam Biotechnology, host rabbit) 1 / 1000, Mel2 (Anti-Melanocyte cell surface antigen antibody, ab128759, Abcam Biotechnology, host mouse) 1 / 500, MATP (sc-377397, Abcam Biotechnology, host Antibody reactions were then carried out at 4℃ overnight after adding anti-tyrosinase antibody (ab738, Abcam Biotechnology, host mouse) at a ratio of 1 / 50 and anti-tyrosinase antibody (ab738, Abcam Biotechnology, host mouse) at a ratio of 1 / 250. The secondary antibodies were incubated at room temperature for 1 hour using 2% BSA / PBS with 0.1% saponin or 2% BSA / PBS alone with Alexa Fluor 594 donkey anti-mouse IgG (Jackson Immuno Research) diluted 1 / 300 and Alexa Fluor 488 donkey anti-rabbit IgG (Jackson Immuno Research) diluted 1 / 500, or Alexa Fluor 488 Goat anti-mouse IgG (Life technologies) diluted 1 / 400 and Alexa Fluor 488 Goat anti-rabbit IgG (Life technologies) diluted 1 / 400. After washing, the specimens were fixed by dropping Mounting Medium with DAPI (Vector Laboratories, Burlingame, CA, USA). The images were then analyzed and photographed using a Keyence fluorescence microscope (Keyence BZ-X700 fluorescence microscope Osaka).
[0023] (5)RT-PCR A 6-well plate (IWAKI) was coated with collagen IV and cultured with induced human adipose tissue-derived stem cells, human adipose tissue-derived stem cells, and melanoma cells as a positive control. Two micrograms of RNA was converted to cDNA using the ReverTra Ace qPCR RT kit (Toyobo, Osaka, Japan). One microgram of cDNA was purified using TaqMan Master Mix (Applied Biosystems, Foster City, CA, USA) and the Step One Plus system (Applied Biosystems) for 50 cycles. Using β-actin as an endogenous control, we confirmed increased expression of HMB45 (Gene Alias: PMEL, Hs00173854_M1), KIT (Hs00174029_M1), MITF (Hs01117294_M1) and PAX3 (Hs00240950_M1). The comparative cycle threshold (ct) method was used to calculate relative mRNA levels using 2-ΔΔCt.
[0024] (6) Knockdown of HMB45 by siRNA The induced human adipose tissue-derived stem cells and human adipose tissue-derived stem cells were seeded onto a 6-well plate (IWAKI) and cultured for two days. Three siRNAs targeting HMB45 were designed using Silencer select siRNA (Thermo Fisher Scientific, USA): siRNA-1 (siRNA ID#: S12861, sense: 5'-GGUUAUCUGGGUCAACAAUtt-3' (SEQ ID NO: 1) and antisense: 3'-AUUGUUGACCCAGAUAACCtg-5' (SEQ ID NO: 2)), siRNA-2 (siRNA ID#: S12859, sense: 5'-AGAAGUUGUGGGUACUACAtt-3' (SEQ ID NO: 3) and antisense: 3'-UGUAGUACCCACAACUUCUgt-5' (SEQ ID NO: 4)), and siRNA-3 (siRNA ID#: S12860, sense: 5'-UAUCAUGCCUGGUCAAGAAtt-3' (SEQ ID NO: 5) and antisense: 3'-UUCUUGACCAGGCAUGAUAag-5' (SEQ ID NO: 6)). Using OptiMem and Lipofectamine RNAi MAX Reagent (Themo Fisher Scientific, USA), 30 pmol of SiRNA1.2.3 was transfected together with siRNA-negative control (Silencer Select #4390843) and siRNA-positive control GAPDH (Silencer Select #4390849). After 48 hours, real-time PCR confirmed that HMB45 expression was suppressed.
[0025] (7) Western blotting A 6-well plate (IWAKI) was coated with collagen IV and cultured with induced human adipose tissue-derived stem cells, human adipose tissue-derived stem cells, and melanocytes as a positive control. Cellular proteins were extracted using M-PER Mammalian Protein Extraction Reagent and a 1 / 100 diluted protease inhibitor cocktail (P8340, Sigma-Aldrich). Electrophoresis was performed using 10% Tris-glycine SDS-PAGE (Bio-Rad, Hercules, CA, USA) and the resultant was transferred to a nitrocellulose membrane. Blocking was performed with 5% skim milk dissolved in Tris-buffered saline. The sections were then immersed in anti-HMB45 antibody (1:100; from Santa Cruz Biotechnology), anti-MITF antibody (1 μg / mL; from Abcam Biotechnology), and β-actin monoclonal antibody (1:2000; BioLegend, San Diego, CA, USA) for primary antibody reaction at 4°C overnight. After washing, secondary antibody reaction was performed at room temperature for 1 hour using anti-mouse peroxidase-conjugated secondary antibody (1:2000, Cell Signaling Technology, USA) and anti-rabbit antibody (1:2000, Cell Signaling Technology, USA). The sections were labeled with SuperSignal West Dura Extended Duration Substrate (Thermo-Scientific, USA) and analyzed using the ImageQuant LAS 4000 system (Cytiva, Tokyo, Japan).
[0026] (8) Immunoelectron microscopy A cover glass was placed on a Nunc4well plate and coated with collagen IV. Induced human adipose tissue-derived stem cells, human adipose tissue-derived stem cells, and melanoma cells were cultured on the cover glass until they reached about 60-70%. The cells were fixed in 4% paraformaldehyde buffered with 0.1 M phosphate buffer (pH 7.2) and left overnight at 4°C. They were then washed three times with PBS, soaked in 0.15% glycine in PBS, and embedded in 12% gelatin in 0.1 M PB. The pellets were then frozen for 1 mm on ice. 3 The tissue was then cut into pieces within 1 mm in diameter, immersed in 2.3 M sucrose in 0.1 MPB at 4° C. overnight, placed in a specimen holder (Leica Microsystems, Vienna, Austria), and stored in liquid nitrogen until use. Sections were cut at a thickness of 400 nm using a Leica UC7 / FC7 at -80°C, attached to a 1:1 mixture of 2% methylcellulose and 2.3 M sucrose, and placed on glass coated with amino propyltriethoxy silane (Matsunami Glass, Kishiwada, Japan). The sections were then incubated with mouse anti-HMB45 antibody (1:50, Abcam ab733, Cambridge, UK) overnight at 4°C, and then incubated with Alexa 488 conjugated donkey anti-mouse IgG (1:200, Invitrogen Life Technologies, Carlsbad, CA) for 1 hour at room temperature. After nuclear staining with DAPI, the sections were mounted in 50% glycerol diluted with distilled water and observed under a BZ-X700 microscope (Keyence, Osaka, Japan). For immunoelectron microscopy, ultrathin frozen sections up to 70 nm thick were prepared at -120°C using a Leica UC7 / FC7. They were then transferred to a nickel grid in a 1:1 mixture of 2% methylcellulose and 2.3 M sucrose. The sections were rinsed in PBS containing 0.15% glycine, washed in PBS containing 1% BSA, and incubated overnight at 4°C with mouse anti-HMB45 antibody (1:5, Abcam ab733, Cambridge, UK). Secondary antibody reactions were performed using donkey anti-mouse IgG conjugated with 12 nm colloidal gold particles (1:40, The Jackson Laboratory, Bar Harbor, ME). Sections were washed with PBS containing 1% GA, embedded in a thin layer of 1.8% methylcellulose with 0.4% uranyl acetate (pH 4.0), dried, and then observed under a Hitachi HT7700 electron microscope (Hitachi, Tokyo, Japan).
[0027] (9) 3D culture The collagen gel solution was prepared by mixing type 1 collagen (3 mg / mL) with a 5-fold concentration of DME and a buffer solution in a ratio of 7:2:1 (purchased from Nitta Gelatin Corp, Osaka, Japan). NHDF (5.0x104-1.0x105 cells / well) embedded in collagen gel are seeded at 750μL / well on a collagen IV-coated IWAKI 12-well cell plate trans well, cultured at 37℃ for 30 minutes, and medium is added above and below. After 2 days, NHEM or induced human adipose tissue-derived stem cells are added at 2.5-5.0x10 4 NHEM was then layered on top of the NHDF collagen gel at 5.0x104 to 1.0x10 cells / well. 5 Seed cells / well. After 15 days of culture, the cells were fixed in 4% PFA and embedded in paraffin. After deparaffinization and activation, they were blocked with normal goat serum (1:200; from Vector Laboratories). Primary antibodies against HMB45 (1:25; from Abcam Biotechnology) and TYR (1:100; from Abcam, Biotechnology) were used to perform primary antibody reactions overnight at 4°C. After washing with PBS, endogenous peroxidase blocking was performed with 0.3% H2O2 / methanol for 30 minutes. After washing, secondary antibody reaction was performed at room temperature for 1 hour using goat anti-mouse biotin IgG secondary antibody (1:300; from Molecular Probe). Avidin (1:300; from DAKO) was used as a labeling reagent and the reaction was performed for 60 minutes. Then, develop the color with DAB (PBS 50mL + DAB 500μL + H2O2 10μL) for 5 minutes, and stain the nuclei with hematoxylin for 1 minute. Wash, dehydrate, clear, mount, and observe under a microscope.
[0028] [result] (1) (The presence of melanocyte precursor cells in adipose tissue stem cells) a) Immunostaining revealed that melanocyte marker proteins Melan A, MATP, HMB45, LAMP1, MITF, TYR, MelEM, and Mel2 were expressed in adipose tissue stem cells (ADSc) before differentiation induction, and their expression was enhanced in these cells (induced Me) cultured in melanocyte culture medium (Figure 1). This was particularly evident in MITF, which is said to be the master gene of melanocytes (Figure 2).
[0029] b) RT-PCR results showed that melanocyte transcription factors MITF, KIT, and PAX3 were expressed in adipose tissue stem cells (22851) prior to differentiation induction, and their expression was enhanced in these cells (induced Me) cultured in melanocyte culture medium (Figures 3-1 and 3-2).
[0030] c) When HMB45 (precursor melanosomal protein) was knocked down in adipose tissue stem cells (22851 cells) using the siRNA method, the expression of HMB45 in these cells disappeared (Figure 4).
[0031] d) Western blotting also showed that HMB45 and MITF were expressed in adipose tissue stem cells (22851) before differentiation induction (Figure 5), and their expression was enhanced in these cells (induced cells) cultured in melanocyte-based culture medium (Figure 6).
[0032] e) Immunoelectron microscopy also showed that HMB45 was expressed in adipose tissue stem cells (ASCs) prior to differentiation induction, and that its expression was enhanced in stimulated ASCs cultured in a melanocyte-based culture medium (Figure 7).
[0033] (2) In 3D culture, melanocyte precursor cells in adipocyte stem cells were induced to differentiate into mature melanocytes. When epidermal models were created by 3D culture of normal human keratinocytes (NHEK) and normal epidermal melanocytes (NHEM), or NHEK and adipose tissue stem cells (induced cells) cultured in melanocyte culture medium, on a collagen gel embedded with fibroblasts, cells expressing tyrosinase (TYR) and HMB45 were found in the basal layer of the epidermis in both culture systems, and a distribution of pigment cells similar to that of normal epidermal structure was reproduced (Figure 8).
Claims
1. A method for producing regenerated human skin tissue containing human mature melanocytes, human keratinocytes and human fibroblasts, comprising seeding and culturing human fibroblasts embedded in a collagen gel onto a trans well, seeding human adipose tissue-derived stem cells induced to become human melanocytes onto the stem cells, and further seeding and culturing human keratinocytes onto the stem cells, wherein the upper trans well contains a melanocyte-specific medium.
2. A method for producing regenerated human skin tissue as described in claim 1, wherein the human adipose tissue-derived stem cells induced to become human melanocytes are human adipose tissue precursor cells containing human melanocyte precursor cells cultured in a melanocyte-specific medium.
Citation Information
Patent Citations
Functional pigmented skin equivalent
JP2009219491A
Artificial skin and method for producing the same
JP2016016267A
